Chiquete Erwin, Aldrete-Velasco Jorge, Juárez-Comboni Sonia C, Solar-Cafaggi David, Durán-Coyote Salvador, Ramos Mercedes Scarlett Enriquez, Camacho-Silva Benjamín, Ochoa-Guzmán Ana, Cantú-Brito Carlos
Instituto Nacional de Ciencias Médicas y de la Nutrición Salvador Zubirán, Mexico.
Internal Medicine and Clinical Research. Paracelsus S.A. de C.V. Mexico City, Mexico.
Arch Med Sci. 2022 May 29;21(1):67-74. doi: 10.5114/aoms/150436. eCollection 2025.
In Mexico, cardiovascular diseases (CVD) represent the most important cause of mortality, disability, and premature death. We aimed to analyze the mortality rate due to specific causes of atherothrombotic CVD, from 2011 to 2015.
We analyzed 3,105,975 death certificates issued between January 2011 and December 2015. The 10th version of the codes published by the International Classification of Diseases (ICD) was used to select CVD death records for ischemic heart disease, heart failure, cerebrovascular disease, and peripheral artery disease. Regional analyses from the different federal states were also performed to provide inferences on the economic regions of the country.
We analyzed 594,370 (19.1%) death certificates with CVD as the basic cause of death occurring in Mexico during 2011-2015. Age-standardized CVD mortality showed a more stable pattern, from 96.7 per 100,000 people in 2011, to 111.7 per 100,000 in 2015. Cause-specific mortality rates increased more during the period for ischemic heart disease (63.8 vs. 74.8 per 100,000 people, in 2011 vs. 2015, respectively), as compared to heart failure (6.9 vs. 8.1 per 100,000 people), cerebrovascular disease (28.4 vs. 30.2 per 100,000 people), or peripheral artery disease (0.52 vs. 0.55 per 100,000 people). Overall, the survival age was significantly shorter in men (mean age at death 72.04 ±16.23 years) than in women (77.73 ±14.77). Ischemic heart disease and cerebrovascular disease showed the shortest survival. The number of deaths increased steadily among the older population, with the steepest increase for overall ischemic heart disease over time.
Atherothrombotic CVD mortality in Mexico increased during the study period, particularly at the expense of ischemic heart disease. Compared to their counterparts, survival age was shorter in men and in patients with ischemic heart disease and stroke.
在墨西哥，心血管疾病（CVD）是导致死亡、残疾和过早死亡的最重要原因。我们旨在分析2011年至2015年因动脉粥样硬化性心血管疾病的特定病因导致的死亡率。
我们分析了2011年1月至2015年12月期间发放的3105975份死亡证明。使用国际疾病分类（ICD）发布的第10版编码来选择缺血性心脏病、心力衰竭、脑血管疾病和外周动脉疾病的心血管疾病死亡记录。还对不同联邦州进行了区域分析，以推断该国的经济区域情况。
我们分析了2011 - 2015年期间在墨西哥发生的以心血管疾病为根本死因的594370份（19.1%）死亡证明。年龄标准化的心血管疾病死亡率呈现出更稳定的模式，从2011年的每10万人96.7例，上升至2015年的每10万人111.7例。与心力衰竭（2011年每10万人6.9例，2015年每10万人8.1例）、脑血管疾病（2011年每10万人28.4例，2015年每10万人30.2例）或外周动脉疾病（2011年每10万人0.52例，2015年每10万人0.55例）相比，缺血性心脏病在该期间的特定病因死亡率上升幅度更大（分别为2011年每10万人63.8例，2015年每10万人74.8例）。总体而言，男性的生存年龄（死亡时平均年龄72.04±16.23岁）明显短于女性（77.73±14.77岁）。缺血性心脏病和脑血管疾病的生存时间最短。老年人群中的死亡人数稳步增加，随着时间推移，总体缺血性心脏病的增长最为显著。
在研究期间，墨西哥动脉粥样硬化性心血管疾病的死亡率有所上升，尤其是以缺血性心脏病为代价。与女性相比，男性以及患有缺血性心脏病和中风的患者的生存年龄较短。
